AVX AVAX ONE TECHNOLOGY LTD. Insider Trading

CFO Polimeni buys 2,500 shares of AVX at $1.75 as stock down -65.4% from 52-week high

Polimeni Christopher Vincent, Chief Financial Officer of AVAX ONE TECHNOLOGY LTD., purchased 2,500 shares at $1.75 on 2025-11-21, increasing his holdings from 105,485 to 107,985 shares. The purchase occurred when the stock traded at $1.75, which is now $0.98 above the current price of $0.73, and represents a point -65.4% below the 52-week high of $2.11. The company reported a net income of $-8,351,326.00 for its most recent full fiscal year, despite showing annual revenue growth of +317.0% to $525,915.00 in the latest quarter. The stock has declined -57.8% over the past 30 days and -61.8% over the past 90 days, establishing a context of significant downward pressure. The modest size of this purchase and continued unprofitability warrant attention to whether this reflects insider assessment or is incidental positioning.

CEO Jolie buys 4,000 shares at $1.66–$1.70 as stock trades at $0.67, down 68.2% from 52-week high.

JOLIE (Chief Executive Officer) acquired 4,000 shares across 2 separate purchases on 2025-11-21 and 2025-11-24, bringing holdings from 167.6K to 171.6K shares (+2.4%). The blended purchase price was $1.66, significantly above the current price of $0.67, representing a 60% decline from the transaction prices. The company's recent quarterly revenue was $525.9K, but net income was $-8.4M (unprofitable), and the stock has fallen 57.9% over the past 30 days and 55.3% over 90 days. The 52-week range of $0.63–$2.11 indicates the CEO acquired at prices closer to mid-range rather than near recent lows. The contrast between the acquisition prices and current valuation, combined with ongoing losses and sharp recent price declines, raises questions about the timing and rationale for the purchase at that price level relative to current market conditions.

Director David Ryan Welch purchases 11 shares at $129.42; trivial 0.0% increase to 97.4K holdings

David Ryan Welch purchased 11 shares for a total value of $1,423.62 on 2024-05-17, increasing his holdings to 97,421 shares with a net change of purchased 11 shares (+0.0% vs pre-transaction holdings). The transaction occurred at $129.42 per share, while the current price is $3.25—a 97.5% decline from the transaction price. AGRI is trading at -52.5% from its 52-week high of $6.84 and has experienced significant volatility, with a 30-day change of +34.3% and 90-day change of +335.1%. The company remains fundamentally troubled: it reported net income of $-8,060,242.00 on revenue of $451,955.00 (latest quarter) and is unprofitable over its most recent full fiscal year. The minimal share purchase and negligible portfolio impact (+0.0% vs holdings) make this a routine director transaction with limited signaling value in the context of the company's ongoing losses and the severe deterioration in share price since the purchase date.